See “What is the most important information I should know about SPRAVATO®?”. See full eligibility requirements. SPRAVATO® may harm your baby. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO® and their baby. These are not all the possible side effects of SPRAVATO®. Learn how cost assistance programs can help people with … *Some Medicare Part D patients who cannot afford their medicines, and who meet certain financial criteria, may also be eligible for assistance. SPRAVATO, Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO, If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO, There is a pregnancy registry for women who are exposed to SPRAVATO, are breastfeeding or plan to breastfeed. Please Contact the program for … Call the programs or visit their websites to learn more. Janssen CarePath can provide information about other resources that may be able to help with your out-of-pocket medication costs for SPRAVATO ®. Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you: Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Some people taking SPRAVATO® get nausea and vomiting. If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule. What are the possible side effects of SPRAVATO®? *2019 financial assistance amount was determined by the total amount billed to and paid by manufacturer and charitable financial assistance … It is not known if SPRAVATO® is safe or effective as an anesthetic medicine. The active substance in Spravato, esketamine, is an antidepressant. We only can refer you to a foundation that supports your disease state. Esketamine is the s-enantiomer of the anesthetic ketamine, which was first … SPRAVATO® may cause serious side effects including: The most common side effects of SPRAVATO® when used along with an antidepressant taken by mouth include: If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. 5. have ever had a condition called “psychosis” (see, feel, or hear things that are not there, or believe in things that are not true). All rights reserved. help. Call Janssen CarePath at 844-777-2828,Monday–Friday, 8:00 AM to 8:00 PM ET. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine. If you are eligible, the Janssen CarePath Savings Program may provide savings on your out-of-pocket medication costs for SPRAVATO®. Will my insurance cover treatment with SPRAVATO®? If you have Medicare Part D coverage but still have trouble paying for your prescriptions, there are charities that may be able to. Call a Janssen CarePath Care … We can only refer you to a foundation that supports your disease state. †Independent co-pay assistance foundations have their own rules for eligibility. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. feeling disconnected from yourself, your thoughts, feelings and things around you, decreased feeling of sensitivity (numbness). This link is provided for your convenience. Do not take part in these activities until the next day following a restful sleep. Eligible commercially-insured patients pay $10 per treatment for SPRAVATO® medication costs, with a $7,150 maximum program benefit per calendar year. helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on SPRAVATO™ treatment that you prescribed. You should not breastfeed during treatment with SPRAVATO®. During and after each use of the SPRAVATO® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting. Independent co-pay assistance foundations have their own rules for eligibility. All rights reserved. Call your doctor for medical advice about side effects. Program limits apply. Third party trademarks used herein are trademarks of their respective owners. SPRAVATO® can cause serious side effects, including: Sedation and dissociation. Here you'll find the financial assistance programs available for SPRAVATO… Spravato Prices, Coupons and Patient Assistance Programs. Call a Janssen CarePath Care Coordinator at 844-777 … Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. © Janssen Pharmaceuticals, Inc. 2020. Spravato … SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®. Taking SPRAVATO® with certain medicine may cause side effects. We are here to support you during COVID-19. Transfer Rx. © Johnson & Johnson Health Care Systems Inc. 2020. Program limits apply. It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. A report from your pharmacy or an Explanation of Benefits (EOB) statement ... SPRAVATO®* (esketamine) Nasal Spray CIII, for intranasal use ... patient assistance … Depending on how their insurance covers SPRAVATO®, there is a program benefit limit of list price of … Some of these programs may also help … The majority of patients enrolled in the SHARES Copay Assistance … You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®. At Janssen, we don’t want cost to get in the way of treatment you need. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions. Depending on how your insurance covers SPRAVATO®, there is a program benefit limit of list price of the medication and a quantity limit of three devices per day or 23 devices in a 24-day period. Tell your healthcare provider right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you: If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®. If you use commercial or private health insurance to pay for your medication: Janssen CarePath Savings Program for SPRAVATO®, Eligible commercially insured patients pay $10 per treatment for SPRAVATO® medication costs with a $7,150 maximum program benefit per calendar year. Taking SPRAVATO® with certain medicine may cause side effects. This information is provided as a resource for you. Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. We will give you information on your insurance coverage, potential out-of-pocket costs, and treatment support, and identify options that may help … You may report side effects to FDA at 1-800-FDA-1088. Your healthcare provider will show you how to use the SPRAVATO® nasal spray device. There is a pregnancy registry for women who are exposed to SPRAVATO® during pregnancy. Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider. Find out if your state has a program that can help you ». Call a Janssen CarePath Care … The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. Patients treated in outpatient healthcare settings (e.g., medical offices and clinics) must be enrolled in the program. There is a quantity limit of 24 devices in a 24-day period for one use per lifetime. Terms expire at the end of each calendar year and may change. This information is provided as a resource for you. Once you and your healthcare provider have decided SPRAVATO® is right for you, Janssen CarePath can help you find the resources you may need to help get started and stay on track. Keep all follow-up visits with your healthcare provider as scheduled. There is a quantity limit of 24 devices in a 24-day period for one use per lifetime. This information is intended for the use of patients and caregivers in the United States and its territories only. You should not take SPRAVATO® if you are pregnant. If you become pregnant during treatment with SPRAVATO®, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/. Financial and insurance assistance If you need financial support to pay for Spravato, or if you need help understanding your insurance coverage, help is available. Your healthcare provider will tell you how much SPRAVATO® you will take and when you will take it. Terms expire at the end of each calendar year and may change. You and your healthcare provider will decide how long you stay on SPRAVATO® based on how you respond to it and how stable that response is. Please note that this third-party website is not controlled by Janssen or subject to our Privacy Policy. Eligible patients may save up to $2,000 on each SUPPRELIN ® LA prescription after a $10 copay. The Prescribing Information included here may not be appropriate for use outside the United States and its territories. Last updated on . Spravato is a rapid-acting, nasal spray formulation of a non-competitive receptor antagonist N-methyl D-aspartate (NMDA). Treatment may include up to three devices administered on the same day. Laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. Treatment may include up to three devices administered on the same day. NeuroMend Infusion Center is a Risk Evaluation and Mitigation Strategy (REMS) facility certified to provide SPRAVATO™ (esketamine), a nasal spray approved for … If you have any questions about the SPRAVATO ® REMS or need help with certification or enrollment, call 1-855-382-6022 Monday - Friday 8AM - 8PM ET For SPRAVATO ® REMS Program information contact: … Apply for Extra Help. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. This site is published by Johnson & Johnson Health Care Systems Inc. 501(c)(3) independent non-profit organization providing financial assistance to adults and children to cover the cost of prescription drug coinsurance, copayments, deductibles, health insurance premiums … The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage … By acting on these NMDA receptors, esketamine can help … What are the possible side effects of SPRAVATO®? Your healthcare provider will decide when you are ready to leave the healthcare setting. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs. No matter what type of coverage you have – or even if you don’t have coverage – Janssen CarePath can help explain your medication insurance coverage and potential out-of-pocket costs and help find programs that may help you pay for SPRAVATO®. If you qualify for Extra Help… Keep all follow-up visits with your healthcare provider as scheduled. Need help paying for your SPRAVATO® (esketamine) CIII Nasal Spray medication? Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. SPRAVATO® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation). We cannot guarantee a foundation will help you. It is not known if SPRAVATO® is safe and effective in children. To see if you might qualify for assistance, please contact a JJPAF program specialist at 800-652-6227 (Monday–Friday, 9:00 AM to 6:00 PM ET) or visit the foundation website at JJPAF.org. Program does not cover the cost to give you your treatment. Services. NMDA regulates the transmission of signals between cells in brain areas involved in the regulation of mood. Many states have programs for people with limited income and resources that pay some or all of Medicare's premiums and may pay Medicare deductibles and co-insurance. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Please call the Johnson & Johnson Patient Assistance … To view programs that are best suited for you, select your coverage status for SPRAVATO® or view all assistance programs. Full Prescribing Information, including Boxed WARNINGS, Prescribing Information, including Boxed WARNINGS, Receive assistance paying their monthly premium, Have reduced or no prescription co-insurance and co-payments, Adults with treatment-resistant depression (TRD), Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. We do not endorse any particular foundation. SPRAVATO® can cause serious side effects, including: If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®. SPRAVATO® is not for use in children. Thank you for visiting our site. It acts on receptors (targets) in the brain for a substance called NMDA. For full eligibility requirements, click here. other unusual changes in behavior or mood, have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs), have an abnormal connection between your veins and arteries (arteriovenous malformation). Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Janssen CarePath helps verify insurance coverage for your patients, provides reimbursement information, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on the SPRAVATO… Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out. Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you: have ever had a condition called "psychosis" (see, feel, or hear things that are not there, or believe in things that are not true). Spravato (esketamine) nasal spray received FDA approval in March 2019 for Treatment Resistant Depression Therapy. How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member? Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings. The SUPPRELIN ® LA Support Center will contact you if your child is eligible for this copay assistance program.. Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings. You can also click here to learn more about Janssen's COVID-19 response. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms. Because of the risks for sedation, dissociation, and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. Third party trademarks used herein are trademarks of their respective owners. What should I avoid while taking SPRAVATO®?